MedTrace Logo

Radiotherapy + Metronidazole vs Radiotherapy Alone In Improving Treatment Outcomes in Advanced Cervical Cancer in Uganda

NCT01937650 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2013-09-09

No results posted yet for this study

Summary

The objective of the study was to determine whether there was a difference in the effectiveness of Radiotherapy alone compared with Radiotherapy plus Metronidazole in the treatment of women with advanced cancer of the cervix in Mulago hospital. It was a randomized controlled trial composed of 38 women altogether, with one group composed of randomly selected women with advanced cancer of the cervix treated with radiotherapy alone and the other group composed of similar women but treated with radiotherapy and metronidazole.

Conditions

  • Cervix Carcinoma

Interventions

DRUG

Radiotherapy plus metronidazole

Metronidazole was added to the standard radiotherapy that is routinely used.

Sponsors & Collaborators

  • Makerere University

    lead OTHER

Principal Investigators

  • Peter Kibuuka, MBChB · Makerere University

  • Mike Kagawa, MMed · Makerere University

  • Anthony Okoth, MMed · Mulago National Referral Hospital

  • Joseph Kigula-Mugambe, MMed · Mulago National Referral Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-04-30
Completion
2010-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01937650 on ClinicalTrials.gov